Search Results
Nov 07, 2025, 10:38 ET Oficiálne kótovanie SERES na HKEX - využitie duálnych kapitálových platforiem „A+H" na podporu globálnej expanzie
investorov vrátane fondu Chongqing Industrial Mother Fund (Chongqing Industrial Investment Fund of Funds (FoF)), Linyuan Fund, GF Fund, Schroders, China Post Wealth a Xingyu Hong Kong. Zdôraznilo to široké uznanie silných rastových vyhliadok a vysokokvalitného rozvoja spoločnosti SERES zo strany globálnych
More news about: SERES
Nov 07, 2025, 10:30 ET Preimplantation Genetic Testing Market worth $1,135.0 million by 2030 with 10.5% CAGR | MarketsandMarkets™
factors. The rising number of orthopedic surgeries, such as joint replacements, ligament repairs, and fracture treatments, increases the demand for post-operative bracing solutions to support recovery, immobilization, and rehabilitation. These facilities often serve as the initial point of care where
More news about: MarketsandMarkets
Nov 07, 2025, 10:00 ET Giraffe Tools Launches 2025 Black Friday Sale Featuring Exclusive Cleaning Bundles
Key Offers & Benefits Post-Purchase Lottery: Everyone Has a Chance to Win – Only on Official! Throughout the promotion period, a special
More news about: Giraffe Tools
Nov 07, 2025, 09:00 ET Diakonos Oncology Presents Promising Preliminary Data from Phase 1 Study of DOC1021 Cell-Based Immunotherapy in Pancreatic Cancer at Society for Immunotherapy of Cancer 40th Annual Meeting
alive with post-operative survival times of 12.9 to 45.3 months; survival status continues to be monitored. No dose-limiting toxicities were observed. Most common adverse events were mild flu-like symptoms. Post-vaccination
More news about: Diakonos Oncology
Nov 07, 2025, 09:00 ET Marengo Late-Breaking Oral Presentation Highlights Single-Agent, Pan Tumor Activity of Invikafusp Alfa Across PD-1-Resistant Cancers in Phase 2 Clinical Trial at SITC 2025
observed following treatmentIn vivo TIL reprogramming with robust upregulation of TCR signaling, cytotoxicity, and chemokine expression post-treatment, indicating enhanced immune activation within the tumor microenvironmentDownregulation of immune-suppressive factors and upregulation of
More news about: Marengo Therapeutics
Nov 07, 2025, 09:00 ET Unwrap a Magical Holiday Escape at Four Seasons Resort Orlando at Walt Disney World Resort
the resort's complimentary "Pasta & Play" offering, available Thursdays-Saturdays from 6:00-9:00pm. Children ages 4 and up can enjoy complimentary post-dinner activities with the Kids For All Seasons team, with games on the nearby spa lawn, allowing parents a few more peaceful moments together, and
More news about: Four Seasons Resort Orlando at Walt Disney World Resort
Nov 07, 2025, 08:39 ET Indonesia's $3.28 Billion MedTech Import Market Reset: The IVD Bubble Is Over; The Surgical Boom Has Begun
driven by pandemic-specific needs. 2022 Contraction (-19.9%): The market fell to $1.79 billion as post-pandemic normalization set in. Demand for pandemic-related items collapsed, with "Clinical Chemistry" (IVD/testing) plummeting by -72.6% and "Anesthesiology"
More news about: Pure Global
Nov 07, 2025, 08:30 ET Brii Biosciences Announces Publication of Phase 2 ENSURE Study Results in Nature Medicine
results from this publication include: Cohorts 1-3: At 24 weeks post-EOT, HBsAg loss was observed in 4 of 19 participants (21.1%) in Cohort 2 (elebsiran 200 mg + PEG-IFNα) and 6 of 18 participants (33.3%) in Cohort 3 (elebsiran
More news about: Brii Biosciences Limited
Nov 07, 2025, 08:30 ET FDA Approved DARZALEX Faspro® for Adult Patients with High-Risk Smoldering Multiple Myeloma
goal of improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. Having touched one million patient lives in post-marketing use in ten commercialized products in at least one major region and across more than 100 global markets, Halozyme has licensed its ENHANZE®
More news about: Halozyme Therapeutics, Inc.
Nov 07, 2025, 08:12 ET Officiellement cotée à la Bourse de Hong Kong, la société SERES s'appuie sur les deux plateformes de capital « A + H » pour accélérer son expansion mondiale
22 investisseurs de premier plan, dont le fonds de fonds de Chongqing pour les investissements industriels, le fonds du Linyuan, le GF Fund, Schroders, China Post Wealth et Xingyu Hong Kong. Cet important soutien des investisseurs devrait entraîner une réévaluation de la valeur de l'entreprise et établir une nouvelle
More news about: SERES
Nov 07, 2025, 08:00 ET EBR Systems Achieves First Enrollments in the WiSE-UP Study for Heart Failure Patients
The WiSE-UP post-approval study is gathering real-world evidence from commercially treated patients using the WiSE® left ventricular endocardial pacing (LVEP) system.
More news about: EBR Systems
Nov 07, 2025, 08:00 ET Trumid Extends Platform Momentum into October
secondary trading in the first two days after issuance — a new record that highlights the firm's expanding role in grey and new issue market liquidity and post-trade efficiency for clients. More than 10,000 unique bonds traded on Trumid for the tenth consecutive
More news about: Trumid
Nov 07, 2025, 08:00 ET Resolution Therapeutics announces new data showcasing the potential of Regenerative Macrophage Therapy in treating cirrhosis at AASLD 2025
care, long term clinical outcomes data showed (results presented at AASLD 2024) - Improvement in liver function at 90 days post-dose, measured using common biomarkers such as INR and MELD, was associated with favourable long term clinical outcomes - These
More news about: Resolution Therapeutics
Nov 07, 2025, 07:00 ET Enbridge Reports Strong Third Quarter Results, Announces Accretive Investments and Reaffirms 2025 Financial Guidance
secured project backlog. We now have $35 billion of sanctioned growth capital entering service through 2030, as we continue to add visibility to our post-2026 5% annual growth outlook for EBITDA, EPS and DCF/share. Looking ahead, we remain committed to disciplined capital allocation, protecting the balance
More news about: Enbridge Inc.
Nov 07, 2025, 06:59 ET Agricultural Robots Market worth $56.26 billion by 2030- Exclusive Report by MarketsandMarkets™
segment holds a significant share in the agricultural robots market due to the increasing adoption of automation for crop cultivation, harvesting, and post-harvest handling. Farmers are leveraging robotics to enhance productivity, lower operational costs, and maintain consistent yield quality. The growing
More news about: MarketsandMarkets
Nov 07, 2025, 06:57 ET GORE ANNOUNCES POSITIVE CLINICAL TRIAL RESULTS OF THE INVESTIGATIONAL GORE® VIABAHN® FORTEGRA VENOUS STENT FOR TREATMENT OF PATIENTS WITH DEEP VENOUS ILIOCAVAL OBSTRUCTION
its kind to include the inferior vena cava (IVC), iliac and femoral veins. All treated patients had thrombotic disease (acute, subacute, or chronic/post thrombotic syndrome), of which 94.3% had lesions spanning three vessel regions (IVC + bilateral iliofemoral veins), and 68.5% required stents that extended
More news about: W. L. Gore & Associates, Inc. MPD Division
Nov 07, 2025, 06:45 ET TELUS reports strong operational and financial results for third quarter 2025
education, health and well-being for youth across the country. In addition, through the TELUS Student Bursary program, the Foundation provides bursaries for post-secondary students who face financial barriers and are committed to making a difference in their communities. During the first nine months of 2025,
More news about: TELUS Corporation
Nov 07, 2025, 06:12 ET October in Review: 10 Top Health Press Releases
Patients who self-administered NET Device™ stimulation for at least one day stayed longer in the residential program and reported fewer post-discharge days of drug use overall over 3 months. These outcomes could be early indicators of longer-term recovery.
More news about: PR Newswire
Nov 07, 2025, 04:46 ET Automotive Cybersecurity Market Worth USD 14 Bn by 2030 Amid Rising Connected Vehicle Use and Data Security Mandates, Says Mordor Intelligence
Post-Quantum Cryptography Market - The post-quantum cryptography market is valued at USD 0.88 billion in 2025 and projected to reach USD 4.60 billion
More news about: Mordor Intelligence Private Limited
Nov 07, 2025, 04:30 ET LEPAS Elegant Technology Safeguards Every Elegant Journey with Global Five-Star Safety Standards
LEPAS reinterprets Euro NCAP's four independent modules into a crash-scenario-based four-stage framework—risk prediction, collision protection, and post-accident rescue—creating a closed-loop and highly robust safety system. In body-structure safety, Elegant Technology establishes
More news about: Chery Group
Nov 07, 2025, 03:47 ET LEPAS Elegant Technology Safeguards Every Elegant Journey with Global Five-Star Safety Standards
LEPAS reinterprets Euro NCAP's four independent modules into a crash-scenario-based four-stage framework—risk prediction, collision protection, and post-accident rescue—creating a closed-loop and highly robust safety system. In body-structure safety, Elegant Technology establishes
More news about: Chery Group
Nov 07, 2025, 01:02 ET SERES Resmi Catat Saham di HKEX, Manfaatkan Dua Platform Pasar Modal "A+H" untuk Ekspansi Global
Chongqing Industrial Chongqing Industrial Mother Fund (Chongqing Industrial Investment Fund of Funds (FoF), Linyuan Fund, GF Fund, Schroders, China Post Wealth, dan Xingyu Hong Kong. Dukungan luas dari investor global ini mencerminkan kepercayaan terhadap potensi pertumbuhan dan kualitas perkembangan
More news about: SERES
Nov 07, 2025, 00:00 ET SERES、香港証券取引所に正式上場、デュアル「A+H」資本プラットフォームを活用してグローバルな展開を加速
注目すべきことに、今回の公募にはChongqing Industrial Mother Fund（Chongqing Industrial Investment Fund of Funds（FoF））を含む22のコーナーストーン投資家が参加しました。Linyuan Fund、GF Fund、Schroders、China Post Wealth、そしてXingyu Hong Kongなどが名を連ねており、これはSERESの力強い成長見通しと高品質な発展が世界の資本市場から広く認められていることを示しています。このような強力な投資家からの支持は、同社の企業価値の再評価を促し、SERESの投資価値に新たなベンチマークを確立するとともに、資金調達能力と資本効率をさらに高めることが期待されています。
More news about: SERES
Nov 06, 2025, 23:37 ET Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032
goal of improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. Having touched one million patient lives in post-marketing use in ten commercialized products in at least one major region and across more than 100 global markets, Halozyme has licensed its ENHANZE®
More news about: Halozyme Therapeutics, Inc.
Nov 06, 2025, 20:40 ET Seres oficiálně kótován na HKEX, využívá duální kapitálovou platformu „A+H" k podpoře globálního růstu
investorů, mezi nimiž byli Chongqing Industrial Mother Fund (Chongqing Industrial Investment Fund of Funds) (FoF), Linyuan Fund, GF Fund, Schroders, China Post Wealth a Xingyu Hong Kong, což podtrhuje široké uznání silného růstového potenciálu a kvalitního rozvoje společnosti SERES ze strany globálních kapitálových
More news about: SERES